CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study-Reference-Cited by-同舟云学术

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

Published:2015-08 Issue:8 Volume:16 Page:949-956
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cassier Philippe A,Italiano Antoine,Gomez-Roca Carlos A,Le Tourneau Christophe,Toulmonde Maud,Cannarile Michael A,Ries Carola,Brillouet Anne,Müller Claudia,Jegg Anna-Maria,Bröske Ann-Marie,Dembowski Markus,Bray-French Katharine,Freilinger Christine,Meneses-Lorente Georgina,Baehner Monika,Harding Ross,Ratnayake Jayantha,Abiraj Keelara,Gass Nathalie,Noh Karen,Christen Randolph D,Ukarma Lidia,Bompas Emmanuelle,Delord Jean-Pierre,Blay Jean-Yves,Rüttinger Dominik

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapies;Wardelmann;Ann Oncol,2010

2. Tenosynovial giant cell tumour, localized type and diffuse type,2013

3. Pigmented villonodular synovitis;Sirlyn;Sonography,2014

4. Pigmented villonodular synovitis: radiologic-pathologic correlation;Murphey;Radiographics,2008

5. Pigmented villonodular synovitis: current concepts about diagnosis and management;Verspoor;Future Oncol,2013

Cited by 299 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity;Hematology/Oncology Clinics of North America;2024-10

2. Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Microglial and neuronal fates following inhibition of CSF-1R in synucleinopathy mouse model;Brain, Behavior, and Immunity;2024-09

4. An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls;Clinical and Experimental Medicine;2024-07-13

5. Advances in the therapeutic study of oncolytic virus in colorectal cancer;Oncology and Translational Medicine;2024-07-02